These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 7826625)

  • 1. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
    Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
    Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively.
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Nucleic Acids Res; 1993 Dec; 21(24):5609-15. PubMed ID: 8284205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three classes of mammalian transcription activation domain stimulate transcription in Schizosaccharomyces pombe.
    Remacle JE; Albrecht G; Brys R; Braus GH; Huylebroeck D
    EMBO J; 1997 Sep; 16(18):5722-9. PubMed ID: 9312030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBP-like protein (TLP/TLF/TRF2) artificially recruited to a promoter stimulates basal transcription in vivo.
    Ohbayashi T; Shimada M; Nakadai T; Tamura TA
    Biochem Biophys Res Commun; 2001 Jul; 285(3):616-22. PubMed ID: 11453637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity.
    Fujii M; Tsuchiya H; Seiki M
    Oncogene; 1991 Dec; 6(12):2349-52. PubMed ID: 1766679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
    Veschambre P; Simard P; Jalinot P
    J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.
    Xiao H; Lis JT; Xiao H; Greenblatt J; Friesen JD
    Nucleic Acids Res; 1994 Jun; 22(11):1966-73. PubMed ID: 8029001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting a promoter-bound protein to TBP bypasses the need for a transcriptional activation domain.
    Chatterjee S; Struhl K
    Nature; 1995 Apr; 374(6525):820-2. PubMed ID: 7723828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of transcriptional activation and repression can both involve TFIID.
    Manley JL; Um M; Li C; Ashali H
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):517-26. PubMed ID: 8735274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAFs mediate transcriptional activation and promoter selectivity.
    Verrijzer CP; Tjian R
    Trends Biochem Sci; 1996 Sep; 21(9):338-42. PubMed ID: 8870497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
    Chang CH; Scott GK; Baldwin MA; Benz CC
    Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemistry of transcription in eukaryotes: a paradigm for multisubunit regulatory complexes.
    Tjian R
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):491-9. PubMed ID: 8735271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
    Ghosh S; Selby MJ; Peterlin BM
    J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal promoter elements as a selective determinant of transcriptional activator function.
    Das G; Hinkley CS; Herr W
    Nature; 1995 Apr; 374(6523):657-60. PubMed ID: 7715708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast.
    Struhl K
    Nature; 1988 Apr; 332(6165):649-50. PubMed ID: 3128739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAF(II)170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity.
    Pereira LA; van der Knaap JA; van den Boom V; van den Heuvel FA; Timmers HT
    Mol Cell Biol; 2001 Nov; 21(21):7523-34. PubMed ID: 11585931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA polymerase II C-terminal repeat influences response to transcriptional enhancer signals.
    Scafe C; Chao D; Lopes J; Hirsch JP; Henry S; Young RA
    Nature; 1990 Oct; 347(6292):491-4. PubMed ID: 2215664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroendocrine protein 7B2 contains unusually potent transcriptional activating sequences.
    Chaudhuri B; Huijbregts RP; Coen JJ; Fürst P
    Biochem Biophys Res Commun; 1995 Nov; 216(1):1-10. PubMed ID: 7488073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.